Several reports have suggested that Trop2 expression regulates tumor cell resistance to therapeutic drugs, including tamoxifen and trastuzumab, among others [41,42], which could be explained by its effect regulating the Notch1 signaling pathway in some cells. Here, TACSTD2 is linked to neoplasm.